Načítá se...
Pharmacokinetics and Safety of Rifamycin SV after Single and Multiple Doses of MMX(®) Modified Release Tablets in Healthy Male and Female Volunteers
The primary objective of this single- and multiple-dose pharmacokinetic study was the investigation of rifamycin SV’s pharmacokinetic profile in plasma and urine. All the 18 enrolled healthy men and post-menopausal women received modified release tablets containing 600 mg of the oral non-absorbable...
Uloženo v:
| Vydáno v: | Antibiotics (Basel) |
|---|---|
| Hlavní autoři: | , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
MDPI
2021
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7915865/ https://ncbi.nlm.nih.gov/pubmed/33562091 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/antibiotics10020167 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|